X. Long Zheng: Novel Gain-of-Function ADAMTS13 Variant with Potential Therapeutic Impact
X. Long Zheng, Professor and Chair of Pathology and Laboratory Medicine at The University of Kansas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Hot off the press in the Journal of Thrombosis and Haemostasis (JTH) from Szumam Liu et al. about a novel gain-of-funtion ADAMTS13 variant that may have therapeutic implications.
Thank you all for your hardworking and close collaboration.”
Title: ADAMTS13 R1206K Variant Exhibits an Open Conformation and Enhanced Proteolytic Activity toward von Willebrand factor
Authors: Szumam Liu, Xiaxin Dong, Quintijn Bonnez, Zhirong Chai, Chan Meng, Madison Gil, Karen Vanhoorelbeke, Konstantine Halkidis, X. Long Zheng
Read the Full Article on Journal of Thrombosis and Haemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 30, 2026, 15:14Alok Khorana: Six Years of Transformation, A Lifetime Commitment to Change
-
Mar 30, 2026, 15:06Carlos Andrés Vergara Sánchez: Simultaneous Publications and Live Presentations at ACC26
-
Mar 30, 2026, 15:05Connecting with More Than 900 Healthcare Leaders at THSNA – PDSA
-
Mar 30, 2026, 14:32Jecko Thachil: Elevated Ferritin in the Absence of Iron Overload
-
Mar 30, 2026, 14:26Michael Baria: Key Findings on the Impact of Exercise on PRP
-
Mar 30, 2026, 14:25Training the Next Generation in Hemostasis through IAHAD Masterclass – IAHAD
-
Mar 30, 2026, 14:25Christopher Robinson: Understanding Lateral Hysterotomy Hematoma in Cesarean Delivery
-
Mar 30, 2026, 14:24Heghine Khachatryan: Reversible Causes of Dementia from a Hematologic Perspective
-
Mar 30, 2026, 14:22Thierry Burnouf: Platelet-Derived Products as Acellular Biotherapies for Neurological Disorders